Trial Profile
Effects of oral nicorandil on contrast-induced nephropathy in coronary artery disease with renal insufficiency after percutaneous coronary intervention
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 29 Sep 2017
Price :
$35
*
At a glance
- Drugs Nicorandil (Primary)
- Indications Kidney disorders
- Focus Therapeutic Use
- 29 Sep 2017 New trial record